Multicenter, randomized, double-blind placebo in Phase I to evaluate safety of oral ALK lyophilized mite in children [Estudio multicéntrico, randomizado, doble ciego-placebo en Fase I para evaluar la seguridad en niños del liofilizado oral ALK de ácaros]

Trial Profile

Multicenter, randomized, double-blind placebo in Phase I to evaluate safety of oral ALK lyophilized mite in children [Estudio multicéntrico, randomizado, doble ciego-placebo en Fase I para evaluar la seguridad en niños del liofilizado oral ALK de ácaros]

Recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Aug 2011

At a glance

  • Drugs House dust mite allergy immunotherapy-ALK Abello (Primary)
  • Indications Allergic asthma; Allergic rhinoconjunctivitis
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors ALK-Abello
  • Most Recent Events

    • 29 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top